Pharmacy Times

JULY 1, 2025

SHOW MORE Pharmacists can help oversee the treatment process to ensure patients with transthyretin amyloid cardiomyopathy (ATTR-CM) are adhering to tafamidis. Ongoing research explores tafamidis' long-term efficacy, potential in other heart failure forms, and combination therapies for enhanced outcomes.

HIV Treatment and Prevention Agents 111

HIV Treatment and Prevention Agents Specialty Pharmacies Compounding Pharmacies Hospitals 111

Pharmaceutical Technology

JULY 2, 2025

Gilead’s recently approved drug for HIV prevention, Yeztugo (lenacapavir), has the potential to transform the pre-exposure prophylaxis (PrEP) sector in the US, according to market analysts. Go deeper with GlobalData Reports LOA and PTSR Model - BRII-732 in Human Immunodeficiency Virus (HIV).

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Packaging FDA Communication 52

Pharmaceutical Technology

JUNE 11, 2025

The US Food and Drug Administration (FDA) has placed a clinical hold on several of Gilead’s trials evaluating two HIV treatment candidates, though the rest of the drugmaker’s diverse pipeline remains unaffected. Gilead is considered the leading big pharma in HIV treatments. Shares in Nasdaq-listed Gilead opened 0.3%

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents FDA Communication Hospitals 52

The Thyroid Pharmacist

JULY 20, 2023

You can self-order the labs and later submit them to your insurance for potential reimbursement (please check with your individual insurance to make sure they will cover the test). Even if your insurance doesn’t cover it, the ferritin test is not expensive, and you can use your Health Savings Account in most cases.

Health and Personal Care Stores 98

Health and Personal Care Stores HIV Treatment and Prevention Agents Insurance Immunization 98